Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells 1,604 Shares of Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 1,604 shares of NeueHealth stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $7.06, for a total value of $11,324.24. Following the transaction, the chief executive officer now owns 184,717 shares of the company’s stock, valued at $1,304,102.02. This represents a 0.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Price Performance

NEUE traded up $0.02 during trading on Tuesday, hitting $6.92. The stock had a trading volume of 16,513 shares, compared to its average volume of 24,929. The firm has a market cap of $57.33 million, a price-to-earnings ratio of -0.14 and a beta of 0.56. The company has a 50 day moving average price of $7.33 and a 200-day moving average price of $5.99. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $8.32.

Institutional Investors Weigh In On NeueHealth

A number of institutional investors have recently modified their holdings of NEUE. Virtu Financial LLC acquired a new stake in NeueHealth in the 4th quarter worth about $76,000. Northern Trust Corp grew its position in shares of NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares in the last quarter. Finally, Partners Group Holding AG bought a new position in shares of NeueHealth during the third quarter worth approximately $463,000. Institutional investors own 63.88% of the company’s stock.

Analysts Set New Price Targets

Separately, Royal Bank of Canada cut their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.